DK0891326T3 - Nye D-vitaminanaloger - Google Patents
Nye D-vitaminanalogerInfo
- Publication number
- DK0891326T3 DK0891326T3 DK97917272T DK97917272T DK0891326T3 DK 0891326 T3 DK0891326 T3 DK 0891326T3 DK 97917272 T DK97917272 T DK 97917272T DK 97917272 T DK97917272 T DK 97917272T DK 0891326 T3 DK0891326 T3 DK 0891326T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- analogs
- new vitamin
- sec
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9607034.7A GB9607034D0 (en) | 1996-04-03 | 1996-04-03 | Chemical compounds |
| PCT/DK1997/000128 WO1997037972A1 (en) | 1996-04-03 | 1997-03-21 | Novel vitamin d analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0891326T3 true DK0891326T3 (da) | 2002-01-28 |
Family
ID=10791549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97917272T DK0891326T3 (da) | 1996-04-03 | 1997-03-21 | Nye D-vitaminanaloger |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5932565A (ru) |
| EP (1) | EP0891326B1 (ru) |
| JP (1) | JP2000508635A (ru) |
| KR (1) | KR100478741B1 (ru) |
| CN (1) | CN1075809C (ru) |
| AT (1) | ATE206394T1 (ru) |
| AU (1) | AU713630B2 (ru) |
| CZ (1) | CZ290097B6 (ru) |
| DE (1) | DE69707121T2 (ru) |
| DK (1) | DK0891326T3 (ru) |
| ES (1) | ES2163144T3 (ru) |
| GB (1) | GB9607034D0 (ru) |
| HU (1) | HUP9901600A3 (ru) |
| NZ (1) | NZ329531A (ru) |
| PL (1) | PL186771B1 (ru) |
| PT (1) | PT891326E (ru) |
| RO (1) | RO118286B1 (ru) |
| RU (1) | RU2169142C2 (ru) |
| WO (1) | WO1997037972A1 (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001030751A2 (en) * | 1999-10-25 | 2001-05-03 | Strakan Limited | USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF |
| US6989377B2 (en) | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
| US6358939B1 (en) | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| EP1270556A4 (en) | 2000-03-30 | 2005-01-12 | Teijin Ltd | VITAMIN D INTERMEDIATES AND METHODS OF MAKING THE SAME |
| US20080293647A1 (en) | 2004-11-12 | 2008-11-27 | Luciano Adorini | Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer |
| BRPI1007415A2 (pt) | 2009-01-27 | 2016-02-16 | Berg Biosystems Llc | vitamina d3 e análogos da mesma para aliviar os efeitos colaterais associados com quimioterapia |
| CA2770683C (en) | 2009-08-14 | 2018-09-04 | Berg Biosystems, Llc | Vitamin d3 and analogs thereof for treating alopecia |
| SG11201509715UA (en) | 2013-05-29 | 2015-12-30 | Berg Llc | Preventing or mitigating chemotherapy induced alopecia using vitamin d |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE143007T1 (de) * | 1991-07-05 | 1996-10-15 | Duphar Int Res | Vitamin-d derivat, verfahren zu dessen herstellung sowie zwischenprodukte dafür |
| JP3493037B2 (ja) * | 1991-12-18 | 2004-02-03 | 中外製薬株式会社 | ２２−オキサコレカルシフェロール誘導体とその製造方法 |
-
1996
- 1996-04-03 GB GBGB9607034.7A patent/GB9607034D0/en active Pending
-
1997
- 1997-03-21 RU RU98119976/04A patent/RU2169142C2/ru not_active IP Right Cessation
- 1997-03-21 ES ES97917272T patent/ES2163144T3/es not_active Expired - Lifetime
- 1997-03-21 PT PT97917272T patent/PT891326E/pt unknown
- 1997-03-21 AT AT97917272T patent/ATE206394T1/de not_active IP Right Cessation
- 1997-03-21 EP EP97917272A patent/EP0891326B1/en not_active Expired - Lifetime
- 1997-03-21 CN CN97190740A patent/CN1075809C/zh not_active Expired - Fee Related
- 1997-03-21 US US08/983,293 patent/US5932565A/en not_active Expired - Fee Related
- 1997-03-21 NZ NZ329531A patent/NZ329531A/en unknown
- 1997-03-21 JP JP9535756A patent/JP2000508635A/ja not_active Ceased
- 1997-03-21 HU HU9901600A patent/HUP9901600A3/hu unknown
- 1997-03-21 WO PCT/DK1997/000128 patent/WO1997037972A1/en active IP Right Grant
- 1997-03-21 DK DK97917272T patent/DK0891326T3/da active
- 1997-03-21 PL PL97324635A patent/PL186771B1/pl not_active IP Right Cessation
- 1997-03-21 RO RO98-00072A patent/RO118286B1/ro unknown
- 1997-03-21 CZ CZ19988A patent/CZ290097B6/cs unknown
- 1997-03-21 KR KR10-1998-0700504A patent/KR100478741B1/ko not_active IP Right Cessation
- 1997-03-21 DE DE69707121T patent/DE69707121T2/de not_active Expired - Fee Related
- 1997-03-21 AU AU25670/97A patent/AU713630B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69707121T2 (de) | 2002-07-11 |
| HUP9901600A2 (hu) | 1999-09-28 |
| CZ290097B6 (cs) | 2002-05-15 |
| ATE206394T1 (de) | 2001-10-15 |
| US5932565A (en) | 1999-08-03 |
| EP0891326B1 (en) | 2001-10-04 |
| WO1997037972A1 (en) | 1997-10-16 |
| PL324635A1 (en) | 1998-06-08 |
| ES2163144T3 (es) | 2002-01-16 |
| CZ898A3 (cs) | 1998-06-17 |
| CN1196720A (zh) | 1998-10-21 |
| GB9607034D0 (en) | 1996-06-05 |
| KR100478741B1 (ko) | 2005-07-07 |
| AU2567097A (en) | 1997-10-29 |
| JP2000508635A (ja) | 2000-07-11 |
| RO118286B1 (ro) | 2003-04-30 |
| PL186771B1 (pl) | 2004-02-27 |
| AU713630B2 (en) | 1999-12-09 |
| RU2169142C2 (ru) | 2001-06-20 |
| CN1075809C (zh) | 2001-12-05 |
| HUP9901600A3 (en) | 1999-11-29 |
| KR19990035844A (ko) | 1999-05-25 |
| DE69707121D1 (de) | 2001-11-08 |
| EP0891326A1 (en) | 1999-01-20 |
| PT891326E (pt) | 2002-03-28 |
| NZ329531A (en) | 2001-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200100451A1 (ru) | Замещенные аналоги бензопирана для лечения воспаления | |
| DK0687268T3 (da) | Spiroazacykliske derivater som substans P-antagonister | |
| SE9504661D0 (sv) | New compounds | |
| ATE149497T1 (de) | Azanorbornanderivate | |
| UY26130A1 (es) | Compuestos para tratar la obesidad | |
| SE9604786D0 (sv) | New compounds | |
| SE9502921D0 (sv) | New compounds | |
| BR0115936A (pt) | 2-anilino-benzimidazóis substituìdos e sua aplicação como inibidores de nhe | |
| NO984330L (no) | Benzopyranderivater som har leukotrien-antagonistisk virkning | |
| DK0891326T3 (da) | Nye D-vitaminanaloger | |
| NO20014240D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| ATE345117T1 (de) | Biphenylverbindungen sowie ihre anwendung als östrogene mittel | |
| SE9504662D0 (sv) | New compounds | |
| UY26265A1 (es) | Compuestos calciolíticos | |
| ES2089993T1 (es) | Procedimiento y productos intermediarios para la preparacion de clorhidrato de terazosin dihidrato. | |
| YU4393A (sr) | Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni | |
| ATE247649T1 (de) | Disubstituierte biphenyloxazoline | |
| CO5150221A1 (es) | Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas | |
| ES2140683T3 (es) | Procedimiento para preparar compuestos de benzopirano. | |
| SE9802207D0 (sv) | Novel compounds | |
| ATE243695T1 (de) | 5-bicycloindolverbindungen | |
| ATE285230T1 (de) | Verwendung von chrysanthon-naturstoffen, die eine antiangiogene wirkung haben |